Global Infectious Diseases Diagnostics Market Size Study, by Product & Service (Assays, Kits, Reagents, Instruments, Services & Software) by Technology (Immunodiagnostics, Clinic Microbiology, DNA Microarray) by Disease Type (Tuberculosis, HAIS, HIV, Hepatitis) by End Use (Hospital, Physician Offices, Others) by Regional Forecasts 2017-2025
![](/report_cover/10760/global-infectious-diseases-diagnostics-market-size-study-by-product-service_en.gif)
Global Infectious Diseases Diagnostics Market valued approximately USD 14 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6 % over the forecast period 2017-2025. Growing prevalence of infectious diseases across the globe, increasing funding for research for infectious disease diagnostics and the change in focus from centralized laboratories to decentralized point-of-care testing. Infectious disease diagnostics are several techniques used by professionals to diagnose and detect pathogens in human samples such as throat swab, urine, serum, blood, and stool.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, Bio-Rad Laboratories, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Infectious Diseases Diagnostics Market in Market Study:
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
- Assays, Kits, Reagents
- Instruments
- Services & Software
- Immunodiagnostics
- Clinic Microbiology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Sequencing & Next-Generation Sequencing
- DNA Microarray
- Other Technologies
- Hepatitis
- Hepatitis Diagnostics Market
- Human Immunodeficiency Virus (HIV)
- Chlamydia Trachomatis Genital Infection & Gonorrhea
- Hospital-Acquired Infection (HAIS)
- Tuberculosis
- Tuberculosis Diagnostic Market
- Influenza
- Influenza Diagnostics Market
- Other Infectious Diseases
- Hospitals/Clinical Laboratories
- Reference Laboratories
- Physician Offices
- Academic/Research Institutes
- Others
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Mexico
- Rest of the World
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, Bio-Rad Laboratories, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Infectious Diseases Diagnostics Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
CHAPTER 1. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET DEFINITION AND SCOPE
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
5.3.1. Assays, Kits, Reagents
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Instruments
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Services & Software
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
6.3.1. Immunodiagnostics
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Clinic Microbiology
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Polymerase Chain Reaction (PCR)
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. DNA Sequencing & Next-Generation Sequencing
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.6. DNA Microarray
6.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.7. Other technologies
6.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY DISEASE TYPE
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
7.3.1. Hepatitis
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Hepatitis Sub Segments breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3.1. Hepatitis Diagnostics Market
7.3.2. Human Immunodeficiency Virus (HIV)
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Chlamydia Trachomatis Genital Infection & Gonorrhoea (CT/NG)
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Hospital-Acquired Infection (HAIS)
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.5. Tuberculosis
7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.5.3. Tuberculosis (TB) Sub Segment breakdown estimates & forecast, 2015-2025 (USD Billion)
7.3.5.3.1. Tuberculosis Diagnostic Market.
7.3.6. Influenza
7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.6.3. Influenza Sub Segment breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.6.3.1. Influenza Diagnostics Market.
7.3.7. Other Infectious Diseases
7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END-USE
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
8.3.1. Hospital/Clinical Laboratories
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Reference Laboratories
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Physician Offices
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Academic/ Research Institutes
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.5. Other End Use.
8.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY REGIONAL ANALYSIS
9.1. Infectious Diseases Diagnostics Market, Regional Market Snapshot (2015-2025)
9.2. North America Infectious Diseases Diagnostics Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Infectious Diseases Diagnostics Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. France
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4. Rest of Europe
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Infectious Diseases Diagnostics Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Infectious Diseases Diagnostics Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott Laboratories
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Becton, Dickinson & Company
10.3.3. Bio-Rad Laboratories
10.3.4. Danaher Corporation
10.3.5. Diasorin
10.3.6. Luminex
10.3.7. Meridian Bioscience
10.3.8. Quidel
10.3.9. Roche Diagnostics
10.3.10. Siemens AG
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
5.3.1. Assays, Kits, Reagents
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Instruments
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Services & Software
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
6.3.1. Immunodiagnostics
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Clinic Microbiology
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Polymerase Chain Reaction (PCR)
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. DNA Sequencing & Next-Generation Sequencing
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.6. DNA Microarray
6.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.7. Other technologies
6.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY DISEASE TYPE
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
7.3.1. Hepatitis
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Hepatitis Sub Segments breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3.1. Hepatitis Diagnostics Market
7.3.2. Human Immunodeficiency Virus (HIV)
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Chlamydia Trachomatis Genital Infection & Gonorrhoea (CT/NG)
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Hospital-Acquired Infection (HAIS)
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.5. Tuberculosis
7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.5.3. Tuberculosis (TB) Sub Segment breakdown estimates & forecast, 2015-2025 (USD Billion)
7.3.5.3.1. Tuberculosis Diagnostic Market.
7.3.6. Influenza
7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.6.3. Influenza Sub Segment breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.6.3.1. Influenza Diagnostics Market.
7.3.7. Other Infectious Diseases
7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END-USE
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
8.3.1. Hospital/Clinical Laboratories
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Reference Laboratories
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Physician Offices
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Academic/ Research Institutes
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.5. Other End Use.
8.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY REGIONAL ANALYSIS
9.1. Infectious Diseases Diagnostics Market, Regional Market Snapshot (2015-2025)
9.2. North America Infectious Diseases Diagnostics Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Infectious Diseases Diagnostics Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. France
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4. Rest of Europe
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Infectious Diseases Diagnostics Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Infectious Diseases Diagnostics Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott Laboratories
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Becton, Dickinson & Company
10.3.3. Bio-Rad Laboratories
10.3.4. Danaher Corporation
10.3.5. Diasorin
10.3.6. Luminex
10.3.7. Meridian Bioscience
10.3.8. Quidel
10.3.9. Roche Diagnostics
10.3.10. Siemens AG